MNPR – monopar therapeutics inc. (US:NASDAQ)
Stock Stats
News
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting [Yahoo! Finance]
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings [Yahoo! Finance]
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
Monopar Therapeutics Inc. (NASDAQ: MNPR) was upgraded by analysts at Jonestrading from a "hold" rating to a "buy" rating. They now have a $2.00 price target on the stock.
Form 8-K Monopar Therapeutics For: Apr 16
Form 8-K Monopar Therapeutics For: Apr 10
Form 4 Monopar Therapeutics For: Mar 31 Filed by: Cittadine Andrew
Form 4 Monopar Therapeutics For: Mar 31 Filed by: Tsuchimoto Kim R
Form 4 Monopar Therapeutics For: Mar 31 Filed by: Robinson Chandler
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.